The pitfalls of managing thrombosis of an Absorb™-treated bifurcation

International Journal of Cardiology

Volumn 174, Issue 3, 2014, Pages

  Schiattarella, Gabriele Giacomo ^a   Magliulo, Fabio ^a   D'Alise, Giuseppe ^a   Mannacio, Vito ^a   Ilardi, Federica ^a   Trimarco, Bruno ^a   Esposito, Giovanni ^a   Cirillo, Plinio ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Bioresorbable vascular scaffold; Coronary bifurcation lesion; Stent thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; HIRULOG; PURINERGIC P2 RECEPTOR ANTAGONIST; PURINERGIC P2Y12 RECEPTOR ANTAGONIST; UNCLASSIFIED DRUG; ZOTAROLIMUS;

AGED; ANGIOCARDIOGRAPHY; BALLOON CATHETER; BIORESORBABLE SCAFFOLD; CASE REPORT; CONTINUOUS INFUSION; CORONARY ARTERY CIRCUMFLEX BRANCH; CORONARY ARTERY OBSTRUCTION; CORONARY BIFURCATION LESION; CORONARY BLOOD VESSEL; DRUG ELUTING STENT; ELECTROCARDIOGRAPHY; HOSPITAL DISCHARGE; HUMAN; INTRAVASCULAR ULTRASOUND; LETTER; MALE; NON ST SEGMENT ELEVATION ACUTE CORONARY SYNDROME; PRIORITY JOURNAL; SINGLE DRUG DOSE; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT MALAPPOSITION; STENT THROMBOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY; VASCULAR GUIDE WIRE; VASCULAR PATENCY; BIODEGRADABLE IMPLANT; CORONARY THROMBOSIS; DISEASE MANAGEMENT; RADIOGRAPHY; TREATMENT OUTCOME;

ABSORBABLE IMPLANTS; AGED; CORONARY THROMBOSIS; DISEASE MANAGEMENT; HUMANS; MALE; TREATMENT OUTCOME;

EID: 84903306834     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2014.04.116     Document Type: Article

References (12)

1. S. Brugaletta, H.M. Garcia-Garcia, Y. Onuma, and P.W. Serruys Everolimus-eluting absorb bioresorbable vascular scaffold: present and future perspectives Expert Rev Med Devices 9 2012 327 338
2. C.M. Agrawal, K.F. Haas, D.A. Leopold, and H.G. Clark Evaluation of poly(l-lactic acid) as a material for intravascular polymeric stents Biomaterials 13 1992 176 182
3. J. Iqbal, Y. Onuma, J. Orniston, A. Abizaid, R. Waksman, and P. Serruys Biresorbable scaffolds: rationale, current status, challenges, and future Eur Heart J 35 2014 753 757
4. J.A. Ormiston, P.W. Serruys, and E. Regar et al. A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (absorb): a prospective open-label trial Lancet 371 2008 899 907
5. P.W. Serruys ABSORB Cohort B Investigators First report of the three year clinical and multi-modality imaging results of the absorb trial evaluating the absorb everolimus eluting bioresorbable vascular scaffold in the treatment of patients with de novo native coronary artery lesions J Am Coll Cardiol 61 2013 E1731
6. Y. Ishibashi, Y. Onuma, and T. Muramatsu et al. Lessons learned from acute and late scaffold failures in the absorb extend trial Eurointervention 2014 Jan 28 pii: 20130722-03. [Epub ahead of print]
7. T.F. Luscher, J. Steffel, and F.R. Eberli et al. Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications Circulation 115 2007 1051 1058
8. M. Jaguszewski, C. Wyss, J. Alibegovic, T.F. Luscher, and C. Templin Acute thrombosis of bioabsorbable scaffold in a patient with acute coronary syndrome Eur Heart J 34 2013 2046
9. D. Fernandez-Rodriguez, S. Brugaletta, S. Otsuki, and M. Sabate Acute absorb bioresorbable vascular scaffold thrombosis in st-segment elevation myocardial infarction: to stent or not to stent? Eurointervention 2013 Dec 13 pii: 20130807-01. Epub ahead of print]
10. V. Dzavik, T. Muramatsu, N. Crooks, S. Nakatani, and Y. Onuma Complex bifurcation percutaneous coronary intervention with the absorb bioresorbable vascular scaffold EuroIntervention 9 2013 888
11. M.J. Grundeken, R.P. Kraak, D.M. de Bruin, and J.J. Wykrzykowska Three-dimensional optical coherence tomography evaluation of a left main bifurcation lesion treated with absorb(r) bioresorbable vascular scaffold including fenestration and dilatation of the side branch Int J Cardiol 168 2013 e107 e108
12. V. Dzavik, and A. Colombo The absorb bioresorbable vascular scaffold in coronary bifurcations: Insights from bench testing JACC Cardiovasc Interv 7 2014 81 88